Orange Book Blog

At the intersection of Patent and FDA Law

Pharma News Briefs

FDA Law Blog has a great post about a very interesting district court decision concerning Apotex’s attempt to market generic Prilosec before AstraZeneca’s pediatric exclusivity expires.
Congress passed FDA reform legislation this week, albeit without provisions for biosimilars. (AP article; FDA Law Blog; PhRMA release).
In the Pipeline is a great blog by a medicinal chemist. This week, it has a post about the importance of patents to drug development.
Globes reported that according to Merrill Lynch analyst Gregg Gilbert, Wyeth and Teva may settle the Protonix litigation.
Pharmalot posted this week on the rising cost of biotech drugs to big pharma.
Spicy IP has an interesting post this week on Indian pharmaceutical lifecycle management.